← Leaderboards
H. David Humes
Innovative Biotherapies, Inc.
$488,197
Attributed
$976,393
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $399.5K · FY2015–18$500K$375K$250K$125K$0
'15
'16
'17
'18
Funding mix
By agency
FDA$976,393 · 1
By mechanism
R01$976,393 · 1
Top collaborators
- Stuart L Goldstein3 shared
Grant awards (3)
Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury$177,778
R01 · FY2018 · FD · contact PI
Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury$399,483
R01 · FY2017 · FD · contact PI
Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury$399,132
R01 · FY2015 · FD · contact PI